Thomas Jennings
Associate Professor
University of Arkansas for Medical Sciences
faculty
Dermatology, College of Medicine
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Dr. Thomas Jennings, Associate Professor of Dermatology at the University of Arkansas for Medical Sciences, directs dermatologic surgery at the Winthrop P. Rockefeller Cancer Institute. His clinical practice focuses on Mohs micrographic surgery, reconstruction of complex surgical wounds, treatment of high-risk cutaneous cancers, and transplant dermatology. He completed a fellowship in procedural dermatology and Mohs micrographic surgery at the University of Alabama Birmingham Medical Center, performing over 1,000 cases during his fellowship.
His research interests include establishing consensus for Mohs micrographic surgical techniques for melanoma and melanoma in situ, as detailed in recent modified Delphi studies. He has also investigated the use and outcomes of fish skin xenografts in dermatologic surgeries and explored vismodegib as an adjuvant treatment for periorbital basal cell carcinoma. His scholarly metrics include an h-index of 9, with 23 total publications and 541 citations.
Research Overview
Using the vast resources of the only academic medical center in the state of Arkansas, Dr. Thomas Jennings provides personalized medical care to each of his patients. As director of dermatologic surgery at the Winthrop P. Rockefeller Cancer Institute, his services include:Mohs micrographic surgeryAesthetic reconstruction of complexsurgical woundsHigh risk cutaneous cancer treatment áTransplant dermatologyDr. Jennings completed a fellowship in procedural dermatology and Mohs micrographic surgery at the University of Alabama Birmingham Medical Center, where he completed over 1000 cases.
Metrics
- h-index: 9
- Publications: 23
- Citations: 541
Selected Publications
- Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study (2024) DOI
- Vismodegib as an adjuvant treatment for periorbital basal cell carcinoma: a case report and review of literature (2024) DOI
- 43582 Use and Outcomes of Fish Skin Xenografts in Mohs and Other Dermatologic Surgeries (2023) DOI
- Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma for Future Clinical Trials: A Modified Delphi Study (2023) DOI
- 28644 Inpatient training modules increase dermatology resident confidence for hospital consults (2021) DOI
Grants & Funding
- HCV NS3: Biological, Biochemical and Structural Analysis NIH Co-Investigator
- HCV NS3 and NS5A: Biochemical Mechanisms and Biological Functions NIH Co-Investigator
- No FP attached Castle Biosciences, Inc. Principal Investigator
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics